Literature DB >> 34730506

Policy in clinical practice: Emergency Medicaid and access to allogeneic stem cell transplant for undocumented immigrants.

Haley M Simpson1, Allison Bock1, Lilia Cervantes1,2.   

Abstract

Entities:  

Mesh：

Year:  2022        PMID： 34730506      PMCID： PMC9313594          DOI： 10.12788/jhm.3681

Source DB:  PubMed          Journal:  J Hosp Med        ISSN： 1553-5592            Impact factor:   2.899


× No keyword cloud information.
  7 in total

1.  The Status of Provision of Standard Outpatient Dialysis for US Undocumented Immigrants with ESKD.

Authors:  Lilia Cervantes; William Mundo; Neil R Powe
Journal:  Clin J Am Soc Nephrol       Date:  2019-06-06       Impact factor: 8.237

2.  Treatment Disparities Faced by Undocumented Workers From Low- and Middle-Income Countries in the United States With Hematologic Malignancies.

Authors:  Sara E Nunnery; Andrew E Fintel; W Clay Jackson; Jason C Chandler; Michael O Ugwueke; Mike G Martin
Journal:  J Natl Compr Canc Netw       Date:  2016-04       Impact factor: 11.908

3.  Clinicians' Perspectives on Providing Emergency-Only Hemodialysis to Undocumented Immigrants: A Qualitative Study.

Authors:  Lilia Cervantes; Sara Richardson; Rajeev Raghavan; Nova Hou; Romana Hasnain-Wynia; Matthew K Wynia; Catherine Kleiner; Michel Chonchol; Allison Tong
Journal:  Ann Intern Med       Date:  2018-05-22       Impact factor: 25.391

Review 4.  Costs and cost-effectiveness of hematopoietic cell transplantation.

Authors:  Jaime M Preussler; Ellen M Denzen; Navneet S Majhail
Journal:  Biol Blood Marrow Transplant       Date:  2012-04-03       Impact factor: 5.742

5.  Patient-reported outcomes and experiences in the transition of undocumented patients from emergency to scheduled hemodialysis.

Authors:  Lilia Cervantes; Allison Tong; Claudia Camacho; Adriana Collings; Neil R Powe
Journal:  Kidney Int       Date:  2020-10-28       Impact factor: 10.612

Review 6.  Hematopoietic stem cell transplantation for patients with AML in first complete remission.

Authors:  Jan J Cornelissen; Didier Blaise
Journal:  Blood       Date:  2015-12-10       Impact factor: 22.113

7.  Cost Effectiveness of Midostaurin in the Treatment of Newly Diagnosed FLT3-Mutated Acute Myeloid Leukemia in the United States.

Authors:  Eytan Stein; Jipan Xie; Emilie Duchesneau; Subrata Bhattacharyya; Umakanth Vudumula; Briana Ndife; Gaetano Bonifacio; Annie Guerin; Nanxin Li; George Joseph
Journal:  Pharmacoeconomics       Date:  2019-02       Impact factor: 4.558
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.